Moberg Pharma Ab Stock Filter Stocks by Fundamentals
MOB Stock | SEK 17.85 0.42 2.41% |
Moberg Pharma AB fundamentals help investors to digest information that contributes to Moberg Pharma's financial success or failures. It also enables traders to predict the movement of Moberg Stock. The fundamental analysis module provides a way to measure Moberg Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Moberg Pharma stock.
Moberg |
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Moberg Fundamentals
Return On Equity | -0.0325 | |||
Return On Asset | -0.0249 | |||
Operating Margin | (97.71) % | |||
Current Valuation | 82.88 M | |||
Shares Outstanding | 98.27 M | |||
Shares Owned By Insiders | 18.07 % | |||
Shares Owned By Institutions | 3.39 % | |||
Price To Earning | 4.77 X | |||
Price To Book | 0.42 X | |||
Price To Sales | 1,098 X | |||
Revenue | 209.68 M | |||
Gross Profit | 207 K | |||
EBITDA | 6.46 M | |||
Net Income | 7.49 M | |||
Cash And Equivalents | 36.6 M | |||
Cash Per Share | 2.82 X | |||
Total Debt | 16.25 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 10.66 X | |||
Book Value Per Share | 5.43 X | |||
Cash Flow From Operations | (15.3 M) | |||
Earnings Per Share | (0.36) X | |||
Target Price | 8.0 | |||
Beta | 0.8 | |||
Market Capitalization | 272.28 M | |||
Total Asset | 450.89 M | |||
Retained Earnings | (65 M) | |||
Working Capital | 360 M | |||
Current Asset | 410 M | |||
Current Liabilities | 50 M | |||
Z Score | 9.6 | |||
Net Asset | 450.89 M |
About Moberg Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Moberg Pharma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Moberg Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Moberg Pharma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.